Functional disorders of ODDI sphincter and gallbladder: analytical review provisions of IV Rome consensus
Abstract
The aim. Analytical review of the provisions of the Rome Consensus IV, dedicated to functional gallbladder disorders and sphincter of Oddi disoders. Functional gallbladder disorders and sphincter of Oddi among the least studied of functional disorders of the gastrointestinal tract. Currently, there are no high-quality studies that can serve as a basis for the development of a fully informed algorithm of diagnosis and treatment of patients with Functional gallbladder disorders and sphincter of Oddi disoders. In turn, obtain new information on the pathogenesis, the optimal methods of diagnosis and treatment of this disease can significantly change ideas about Functional gallbladder disorders and sphincter of Oddi disoders.
About the Authors
M. A. Osadchuk
First Moscow State Medical University n.a. I.M. Sechenov
Russian Federation
Russian Federation
D. V. Balashov
First Moscow State Medical University n.a. I.M. Sechenov
Russian Federation
Russian Federation
I. L. Davydkin
Samara State Medical University
Russian Federation
Russian Federation
T. A. Gritsenko
Samara State Medical University
Russian Federation
Russian Federation
A. M. Osadchyuk
Samara State Medical University
Russian Federation
Russian Federation
References
1. Desai A.J., Dong M., Harikumar K.G. et al. Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function. Am J Physiol Gastrointest Liver Physiol. 2015 Sep 1; 309 (5): G377-G386.
2. Bielefeldt K., Saligram S., Zickmund S.L. et al. Cholecystectomy for biliary dyskinesia: how did we get there? // Dig. Dis. Sci. - 2014; 59: 2850-2863.
3. Cote G.A., Imperiale T.F., Schmidt S.E. et al. Similar efficacies of biliary, with or without pancreatic, sphincterotomy in treatment of idiopathic recurrent acute pancreatitis // Gastroenterology. - 2012; 143: 1502-1509 e1.
4. Cotton P. B., Durkalski V., Romagnuolo J. et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial // JAMA. - 2014; 311: 2101-2109.
5. Cotton P. B., Elta G. H., Carter С. R. et al. Gallbladder and Sphincter of Oddi Disorders // Gastroenterology. - 2016; 150: 1420-1429.
6. Lee S.K., Kim M.H., Kim H.J. et al. Electroacupuncture may relax the sphincter of Oddi in humans // Gastrointest. Endosc. - 2001; 53: 211-216.
7. Malik S., Kaushik N., Khalid A. et al. EUS yield in evaluating biliary dilatation in patients with normal serum liver enzymes // Dig. Dis. Sci. - 2007; 52: 508-512.
8. Mazaki T., Mado K., Masuda H. et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis // J. Gastroenterol. - 2014; 49: 343-355.
9. Pariente A., Berthelemy P., Arotcarena R. The underestimated role of opiates in sphincter of Oddi dysfunction // Gastroenterology. - 2013; 144: 1571.
10. Pereira S.P., Gillams A., Sgouros S. N. et al. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III // Gut. - 2007; 56: 809-813.
11. Preston J.F., Diggs B.S., Dolan J.P. et al. Biliary dyskinesia: a surgical disease rarely found outside the United States // Am. J. Surg. - 2015; 209: 799-803.
12. Testoni P.A., Caporuscio S., Bagnolo F. et al. IdIdiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. Am J Gastroenterol. 2000 Jul; 95 (7): 1702-7.
13. Vetrhus M., Berhane T., Soreide O. et al. Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis // J. Gastrointest. Surg. - 2005; 9: 826-831.
14. Vitton V., Delpy R., Gasmi M. et al. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? // Eur. J. Gastroenterol. Hepatol. - 2008; 20:15-21.
15. Wilcox C. M., Varadarajulu S., Eloubei-di M. Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review // Gastrointest Endosc. - 2006; 63: 1037.
16. Wu Q., Cotton P.B., Durkalski V. et al. Sa1499 duloxetine for the treatment of patients with suspected sphincter of Oddi dysfunction: an open-label pilot study // Gastrointest Endosc. - 2011; 73: AB 189.
17. Wan J.F., Chu S.F., Zhou X. et al. Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-a expression. Acta Pharmacol Sin. 2018 May 17.
18. Bahar R., Wong K.A., Liu C.H. et al. Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis. Gastroenterol Hepatol (NY). 2018 Mar; 14 (3): 154-163.
Review
For citations:
Osadchuk M.A., Balashov D.V., Davydkin I.L., Gritsenko T.A., Osadchyuk A.M. Functional disorders of ODDI sphincter and gallbladder: analytical review provisions of IV Rome consensus. Medical alphabet. 2018;2(20):5-9. (In Russ.)
Views:
541
Email this article 